Table 3

Clinical data of 34 cervical SCC patients who received NACT before surgery (n = 34)
Patients Age (year) Selection date Clinical stage NACT efficacy
1 45 2012.1.27 Stage Ib2 Effective
2 34 2012.2.4 Stage IIa Effective
3 36 2012.3.12 Stage IIb Effective
4 47 2012.4.15 Stage Ib2 Not effective
5 57 2012.4.17 Stage Ib2 Effective
6 39 2012.5.15 Stage IIa Effective
7 45 2012.5.18 Stage IIa Effective
8 42 2012.6.3 Stage IIb Not effective
9 32 2012.6.17 Stage Ib2 Effective
10 66 2012.6.26 Stage IIa Not effective
11 59 2012.7.14 Stage IIb Not effective
12 46 2012.8.4 Stage Ib2 Effective
13 49 2012.8.15 Stage IIa Not effective
14 51 2012.8.24 Stage Ib2 Effective
15 35 2012.8.29 Stage Ib2 Effective
16 38 2012.9.16 Stage IIa Not effective
17 40 2012.9.19 Stage Ib2 Effective
18 43 2012.10.7 Stage IIa Effective
19 58 2012.10.11 Stage IIb Effective
20 63 2012.10.17 Stage IIa Not effective
21 53 2012.10.19 Stage Ib2 Effective
22 48 2012.10.25 Stage Ib2 Effective
23 43 2012.10.28 Stage IIa Effective
24 45 2012.11.1 Stage IIb Not effective
25 44 2012.11.5 Stage IIa Effective
26 61 2012.11.16 Stage Ib2 Not effective
27 39 2012.11.23 Stage IIa Effective
28 67 2012.11.25 Stage IIa Effective
29 56 2012.11.30 Stage Ib2 Effective
30 44 2012.12.2 Stage Ib2 Effective
31 33 2012.12.10 Stage IIa Not effective
32 54 2012.12.15 Stage Ib2 Effective
33 57 2012.12.19 Stage IIa Effective
34 49 2012.12.22 Stage Ib2 Effective

Note: SCC, squamous cell carcinoma. NACT, neoadjuvant chemotherapy.

Chen et al.

Chen et al. Diagnostic Pathology 2014 9:88   doi:10.1186/1746-1596-9-88

Open Data